Morepen Rx Limited - Company Profile

It is a pharma public limited company based in Nalagarh, Himachal Pradesh, India, established in 2023.
2023 Nalagarh, Himachal Pradesh, India Active
Last Updated:
About Morepen Rx Limited

Morepen Rx Limited, a active public limited company, was established on 17 March 2023 in Nalagarh, Himachal Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U21001HP2023PLC009940. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹7.08 Cr.

Its leadership includes Shalu Suri (Director), Varun Suri (Whole-Time Director), Sanjay Suri (Director). Past directors included Varun Suri, Sushil Suri, Kushal Suri. Its latest AGM occurred on 06 September 2025, with the balance sheet filed on 31 March 2025. It is based at Village Morepen, Nalagarh Road, Near Baddi, Nalagarh, Himachal Pradesh, 173205.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001HP2023PLC009940

  • Registration Number

    009940

  • Incorporation Date

    17 March 2023

  • Authorized Capital

    ₹8.00 Cr

  • Paid-Up Capital

    ₹7.08 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.00 Cr
  • Paid Up Capital ₹ 7.08 Cr
  • Company Age 2 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Morepen Rx Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Morepen Rx Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Morepen Rx Limited?
Current Directors
Name Designation Appointment Date Status
Shalu Suri Director 17 Mar 2023 Current
Varun Suri Whole-Time Director 17 Mar 2023 Current
Sanjay Suri Director 17 Mar 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Sep 2023 Past
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Non- Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Morepen Rx.

Morepen Rx Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Morepen Rx revenue growth over time
Morepen Rx profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Morepen Rx?

In 2023, Morepen Rx had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Morepen Rx?

Unlock and access historical data on people associated with Morepen Rx, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Morepen Rx, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morepen Rx's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Morepen Rx
Recent Activity within the Organization
  • Annual General Meeting

    Morepen Rx Limited last Annual general meeting of members was held on 06 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Morepen Rx Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was completed.

  • Director Appointment

    Progress on Shalu Suri was appointed as a Director was appointed as a Director on 17 Mar 2023 & has been associated with this company since 2 years 11 months . was documented.

  • Director Appointment

    Progress on Varun Suri was appointed as a Whole-time director was appointed as a Whole-time director on 17 Mar 2023 & has been associated with this company since 2 years 11 months . was documented.

  • Director Appointment

    The activity Sanjay Suri was appointed as a Director was appointed as a Director on 17 Mar 2023 & has been associated with this company since 2 years 11 months . was completed.

  • Company Incorporation

    Progress on Morepen Rx Limited was registered on 17 Mar 2023 with Roc Himachal Pradesh & aged 2 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement
Frequently Asked Questions
What is the CIN of Morepen Rx Limited?

The CIN of Morepen Rx Limited is U21001HP2023PLC009940.

Where is Morepen Rx Limited headquartered?

Morepen Rx Limited is headquartered at Village Morepen, Nalagarh Road, Near Baddi, Nalagarh, Himachal Pradesh, 173205.

When was Morepen Rx Limited incorporated?

Morepen Rx Limited was incorporated on 17 March 2023.

Who are the current directors of Morepen Rx Limited?

The current directors of Morepen Rx Limited are

What is the primary industry of Morepen Rx Limited?

The primary industry of Morepen Rx Limited is Pharma.

Is Morepen Rx Limited a listed company?

Morepen Rx Limited is unlisted.

What is the capital structure of Morepen Rx Limited?

The authorized capital of Morepen Rx Limited is ₹8.00 Cr, and the paid-up capital is ₹7.08 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available